Menu Search
Equities

Otsuka Holdings Co Ltd

OS1:BER

Otsuka Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)54.50
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change+58.43%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:26 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Otsuka Holdings Co., Ltd. is a Japan-based company mainly engaged in the medical and nutraceuticals related business and other businesses. The Company operates through four business segments. The Medical-related segment is engaged in the sale of ethical drugs, and the research development and export of therapeutic drugs. The Nutraceuticals-related segment is engaged in the manufacture, purchase and sale of nutraceuticals-related products, such as functional food and dietary supplements. The Consumer-related segment is engaged in the manufacture and sale of consumer products and mineral water. The Others segment is engaged in the manufacture and sale of chemical products, the manufacture, sale and import of measuring equipment, and the manufacture of synthetic resin molding products.

  • Revenue in JPY (TTM)2.27tn
  • Net income in JPY151.58bn
  • Incorporated2008
  • Employees34.39k
  • Location
    Otsuka Holdings Co LtdShinagawa Grand Central Tower2-16-4, KonanMINATO-KU 108-8241JapanJPN
  • Phone+81 367171410
  • Fax+81 367171409
  • Websitehttps://www.otsuka.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.